Press Releases
Antiviral Drugs Market to Reach a Revenue of US$ 82.9 Billion by 2024

Antiviral Drugs Market

, 14 February 2018 -- Antiviral Drugs Market report categorizes the global market by Disease Indication(Hepatitis Virus Infection, HIV Infection), Product Type (Branded Drugs and Generic Drugs) & Geography

According to Transparency Market Research (TMR), the global antivirus drugs market is likely to exhibit a solid CAGR of 6.40% between 2016 and 2024. The market’s valuation is expected to rise from US$48.3 bn to US$82.9 bn over the forecast period.

Report Overview @

The global antiviral drugs market is segmented by region into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Developed countries in North America and Europe are likely to play a key role in the development of the global antiviral drugs market in the coming years due to the steady availability of advanced medical research infrastructure. North America accounted for more than 50% of the global antiviral drugs market in 2015 and is likely to retain a similar level of dominance through the 2016-2024 forecast period.

Emerging countries in Asia Pacific, Africa, and Latin America could also play important roles in the growth of the global antiviral drugs market in the coming years. The rising prevalence of viral diseases has made these regions crucial for antiviral drug development and thus are likely to carry significant commercial weightage for players in the antiviral drugs market over the coming years.

Request for Sample Copy of Report @

By disease indication, the global antiviral drugs market is segmented into HIV-AIDS, hepatitis, respiratory viruses, and others. The growing prevalence of AIDS is likely to keep it prominent within the international medical research field, leading to steady activity in the global antiviral drugs market in the coming years. Hepatitis has also become a key target for antiviral drugs market players and is likely to draw significant investment in the coming years.

One of the key drivers for the global antiviral drugs market is the steady growth of the medical research sector in emerging Asia Pacific economies such as India, China, and Japan. The rising government support in these countries to indigenous drug development and native pharmaceutical industry players has resulted in a steady opportunity for the global antiviral drugs market. Focusing on collaboration with medical research companies based in Asia Pacific could thus turn out to be a prosperous tactic for players in the global antiviral drugs market over the forecast period.

Request a Brochure of the Report @

The high unmet need for antiviral medication in Africa is also likely to remain a key driver for the global antiviral drugs market over the coming years. Underdeveloped countries in Africa have received firm support from several international medical bodies in order to combat the growing prevalence of viral diseases and the lack of resources to counter the problem, which has led to a promising situation for the antiviral drugs market.

The global antiviral drugs market is reasonably consolidated, with Gilead Sciences holding a majority 51% share in 2015. The high level of consolidation is likely to help the global antiviral drugs market develop sustainably over the 2016-2024 forecast period, as the competitive makeup of the market is unlikely to change. Other leading players in the global antiviral drugs market include Merck & Co. Inc., Mylan NV, F. Hoffman-La Roche Ltd., GlaxoSmithKline Plc, Cipla Inc., AbbVie Inc., and Bristol-Myers Squibb Co. The lucrative opportunity in the antiviral drugs market is, however, likely to draw new players on a consistent basis, leading to the competition in the market intensifying over the coming years.

Enquiry for discount on this report @

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

# # #

Submitted by hawer on Wednesday, 14 February 2018 at 3:47 PM
Category: Health Care & Medical
Related News

Vacuum-assisted Fetal Delivery Systems Market – Latest Trends and Future Growth Study by 2025
Tuesday, 20 Feb 2018

Cell Line Authentication and Characterization Tests Market Future Opportunities 2025
Tuesday, 20 Feb 2018

Pheochromocytoma Market with Current Trends Analysis, 2017 - 2025
Tuesday, 20 Feb 2018

Pet Insurance Market Shares, Strategies and Forecast Worldwide, 2017 - 2025
Tuesday, 20 Feb 2018

Pneumonia Therapeutics Market Growth and Forecast 2017 - 2025
Tuesday, 20 Feb 2018

Related Events

2nd Int'l Congress on Clinical Trials in Oncology & Hemato-Oncology 2018
Monday, 19 Feb 2018

Cardiology at Cancun: Topics in Clinical Cardiology
Monday, 19 Feb 2018

6th Annual Primary Care Winter CME Conference
Monday, 19 Feb 2018

CAR-TCR Summit Europe 2018
Tuesday, 20 Feb 2018

World CNS Summit
Tuesday, 20 Feb 2018

Latest News

The Importance Of A Pen
Tuesday, 20 Feb 2018

Painters in Woodstock, GA Set Record Number of Services in Recent Months
Tuesday, 20 Feb 2018

Sex talk - Phone Sex Chat
Tuesday, 20 Feb 2018

In Vitro Fertilization (IVF) Devices and Consumables Market: Market Size, Driving Players and Indust
Tuesday, 20 Feb 2018

10 Characteristics of Helpful Quality Management Systems
Tuesday, 20 Feb 2018

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 20 February 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • 2nd Int'l Congress on Clinical Trials in Oncology & Hemato-Oncology 2018
  • Cardiology at Cancun: Topics in Clinical Cardiology
  • Tax Wise Workshop
  • 6th Annual Primary Care Winter CME Conference
  • Free Supply Chain Improvement Seminars Sydney CBD

  • Latest Jobs
    Sorry, there are currently no entries posted here.